ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

2025

  • Home
  • 2025
March 21, 2025
Research definition
March 21, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN and PrECOG research results
Do you like it?
0 Read more
March 21, 2025
News in Brief
March 21, 2025
Categories
  • News in Brief

News in Brief, March 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more
February 19, 2025
Dr. O'Dwyer and Dr. Schnall
February 19, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, February 2025

The co-chairs highlight the immense value of Cooperative Group cancer research and the importance of its continued funding
Do you like it?
0 Read more
February 19, 2025
February 19, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EA4232 for Patients With Peripheral T-Cell Lymphoma

This is the first randomized phase 3 study to evaluate autologous stem cell transplantation in patients with this rare and aggressive form of non-Hodgkin lymphoma
Do you like it?
0 Read more
February 19, 2025
Woman on smartphone
February 19, 2025
Categories
  • Special Topics

The Value of Patient-Reported Outcomes in Enhancing the Relevance of Clinical Trials

Patient-reported outcomes research has led to many discoveries that have influenced current research priorities and the way the Group designs its trials
Do you like it?
0 Read more
February 19, 2025
Research definition
February 19, 2025
Categories
  • Trial Results

Top Trial Results of 2024: A Year of Significant Advancements in Cancer Treatment

Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
Do you like it?
0 Read more
February 19, 2025
News in Brief
February 19, 2025
Categories
  • News in Brief

News in Brief, February 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more
June 25, 2025
June 25, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EA4231 for Patients With Aggressive B-cell Lymphoma

This clinical trial is evaluating a new drug combination for patients with B-cell lymphoma that has relapsed after remission or no longer responds to standard treatment
Do you like it?
2 Read more
Prev page
12345

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}